Pioneering a path forward

We are committed to helping healthcare professionals understand, diagnose, and treat rare neuroendocrine diseases.

The melanocortin-4 receptor (MC4R) pathway

A key neurosignaling pathway in the hypothalamus responsible for regulating energy balance.

Acquired hypothalamic obesity

A disease characterized by accelerated and sustained weight gain caused by an injury to the hypothalamus.

Bardet-Biedl syndrome (BBS)

A rare genetic disease.

Medical conferences

Come out and meet us at one of these conferences.

Publications and presentations

Learn about Rhythm’s scientific research through key publications and recent conference presentations.

Resources

We have a variety of resources available to support you.

Contact us

Connect with us to learn more.

Rhythm Pharmaceuticals, Inc.
222 Berkeley Street, 12th Floor
Boston, MA 02116

This website is intended only for United States healthcare professionals.

© 2025, Rhythm Pharmaceuticals, Inc. All Rights Reserved. Rhythm, IMCIVREE, GOLD Academy, LEAD for Rare Obesity, Uncovering Rare Obesity, Pioneering a path forward and their logos are trademarks of Rhythm Pharmaceuticals, Inc.

US-IC1-2200030 (04/2025)